Given that hormone therapy, including ADT and anti-androgens for the last eighty years, has been failed to be a curable approach for metastatic prostate cancers, eliminating the AR protein in prostate cancer cells recently emerged as a realistic solution for a potentially curable result. This evidence concerns the gene AR and metastatic prostate carcinoma.